Test Code VZVPV Varicella-Zoster Virus, Molecular Detection, PCR, Varies
Necessary Information
Specimen source is required.
Specimen Required
Submit only 1 of the following specimens:
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Specimen Type: Body fluid
Sources: Spinal, pleural, peritoneal, ascites, pericardial, amniotic, or ocular
Container/Tube: Sterile container
Specimen Volume: 0.5 mL
Collection Instructions: Do not centrifuge.
Specimen Type: Swab
Sources: Miscellaneous; dermal, eye, nasal, or throat
Supplies:
-Culturette (BBL Culture Swab) (T092)
-M4-RT (T605)
Container/Tube: Multimicrobe media (M4-RT) and ESwabs
Collection Instructions: Place swab back into multimicrobe media (M4-RT, M4, or M5).
Specimen Type: Genital Swab
Sources: Cervix, vagina, urethra, anal/rectal, or other genital sources
Supplies:
-Culturette (BBL Culture Swab) (T092)
-M4-RT (T605)
Container/Tube: Multimicrobe media (M4-RT) (T605) and ESwabs
Collection Instructions: Place swab back into multimicrobe media (M4-RT, M4, or M5).
Specimen Type: Respiratory
Sources: Bronchial washing, bronchoalveolar lavage, nasopharyngeal aspirate or washing, sputum, or tracheal aspirate
Container/Tube: Sterile container
Specimen Volume: 1.5 mL
Specimen Type: Tissue
Sources: Brain, colon, kidney, liver, lung, etc.
Supplies: M4-RT (T605)
Container/Tube:
Preferred: Multimicrobe media (M4-RT)
Acceptable: Sterile container with 1 to 2 mL of sterile saline
Specimen Volume: Entire collection
Collection Instructions: Submit only fresh tissue in a sterile container containing 1 mL to 2 mL of sterile saline or multimicrobe medium (M4-RT, M4, or M5)
Useful For
Rapid (qualitative) detection of varicella-zoster virus DNA in clinical specimens for laboratory diagnosis of disease due to this virus
This test should not be used to screen asymptomatic patients.
Method Name
Real-Time Polymerase Chain Reaction (PCR)/DNA Probe Hybridization
Reporting Name
Varicella-Zoster Virus, PCR, VariesSpecimen Type
VariesSpecimen Minimum Volume
Ocular Fluid and Spinal Fluid: 0.3 mL
Body Fluid (pleural, peritoneal, ascites, and pericardial): See Specimen Required
Respiratory Specimens: 1 mL
Tissue: 2 × 2 mm biopsy
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Refrigerated (preferred) | 7 days | |
Frozen | 7 days |
Reference Values
Negative
Reference values apply to all ages.
Interpretation
Detection of varicella-zoster virus (VZV) DNA in clinical specimens supports the clinical diagnosis of infection due to this virus.
VZV DNA is not detected in cerebrospinal fluid from patients without central nervous system disease caused by this virus.
This LightCycler polymerase chain reaction assay does not yield positive results with other herpesvirus gene targets (herpes simplex virus, cytomegalovirus, Epstein-Barr virus).
Clinical Reference
1. Cinque P, Bossolasco S, Vago L, et al. Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection? Clin Infect Dis. 1997;25(3):634-639
2. Brown M, Scarborough M, Brink N, Manji H, Miller R. Varicella zoster virus-associated neurological disease in HIV-infected patients. Int J STD AIDS. 2001;12(2):79-83
3. Studahl M, Hagberg L, Rekabdar E, Bergstrom T. Herpesvirus DNA detection in cerebrospinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses. Scand J Infect Dis. 2000;32(3):237-248
4. Iten A, Chatelard P, Vuadens P, et al: Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system. J Neurovirol. 1999;5(2):172-180
5. Sauerbrei A. Varicella-zoster virus infections - antiviral therapy and diagnosis. GMS Infect Dis. 2016;4:Doc01. doi:10.3205/id000019
6. Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis. 2016;35(5):723-734. doi:10.1007/s10096-016-2605-0
Day(s) Performed
Monday through Saturday
Report Available
Same day/1 to 4 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
87798
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
VZVPV | Varicella-Zoster Virus, PCR, Varies | 94584-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
VZVS | Specimen Source | 31208-2 |
618332 | Varicella-Zoster Virus PCR | 94584-0 |
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.